Surgisphere Fallout Hits African Nonprofit’s COVID-19 Efforts
Summary
A news article by Catherine Offord in The Scientist reporting that an African nonprofit was walking back its recommendation of a tool, built with Surgisphere Corporation, to help clinicians allocate limited medical equipment among COVID-19 patients. Surgisphere, an Illinois-based company founded in 2008 by vascular surgeon Sapan Desai, failed to obtain independent validation of the datasets behind two high-profile studies in The Lancet and the New England Journal of Medicine. Both papers are now retracted, and the Lancet study on hydroxychloroquine had led the World Health Organization to suspend part of a clinical trial. A June 8 update says Surgisphere's online COVID-19 Response Center and its four web tools were taken down.
Summary drafted by a model from the document's text below and checked by script against that text before publication. It is a navigation aid, not a reading of what the document proves. Where AI is used
Full text
News Surgisphere Fallout Hits African Nonprofit’s COVID-19 Efforts The company had helped develop a tool to aid decision-making in distributing limited medical equipment among coronavirus patients, but two high-profile retractions call into question the validity of Surgisphere’s work in toto . Written by Catherine Offord | 9 min read Save for Later Register for free to listen to this article Listen with Speechify 0:00 9:00 ABOVE: © ISTOCK.COM, FIVEPOINTSIX Update (June 8): Surgisphere’s online COVID-19 Response Center and the four web tools hosted on it have been taken down from the company’s website. A nonprofit organization in Africa that promoted a tool to help clinicians determine how to allocate limited medical resources among COVID-19 patients is walking back its recommendations in the wake of a scandal involving the company that collaborated on the project. Surgisphere Corporation, an Illinois-based company founded in 2008 by vascular surgeon Sapan Desai, has come under fire in recent days for failing to obtain independent validation for datasets used in two high-profile studies in The Lancet and the New England Journal of Medicine . Both papers are now retracted . The Lancet study, which reported safety concerns about the use of the antimalarial drug hydroxychloroquine in coronavirus patients, led the World Health Organization to suspend part of a clinical trial. Testing resumed last week ... Interested in reading more? The Scientist ARCHIVES Become a Member of Receive full access to more than 35 years of archives , as well as TS Digest , digital editions of The Scientist , feature stories , and much more! Join for free today Already a member? Login Here Add The Scientist as a preferred Google source to see more of our trusted coverage. Meet the Author - Catherine Offord After undergraduate research with spiders at the University of Oxford and graduate research with ants at Princeton University, Catherine left arthropods and academia to become a science journalist. She has worked in various guises at The Scientist since 2016. As Senior Editor, she wrote articles for the online and print publications, and edited the magazine’s Notebook , Careers , and Bio Business sections. She reports on subjects ranging from cellular and molecular biology to research misconduct and science policy. Find more of her work at her website . View Full Profile Related Topics Related Research Resources Maxwell® Rapid ccfDNA Kit: Automated Purification of ccfDNA in Under 30 Minutes Product Whatman™ Nuclepore™ Polycarbonate Track-Etched Membranes: Precision track-etched membranes with uniform pores for particle analysis. Product TrueAmp Library Preparation Kit: Precise Prep for Your Target Enrichment Workflow Product NGS Library Preparation Reagents Across the Workflow Article
File and source
- File
- surgisphere-fallout-hits-african-nonprofits-covid-19-efforts--67617.html
- Size
- 211,536 bytes
- SHA-256
- 3ab68391db1d9ea9d01660be74b2f8e3683ffc8f7e2596c3894b28eba6eb1738
- Original
- www.the-scientist.com